COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients. Mult Scler Relat Disord. 2021 Apr; 49:102754.
View in:
PubMed
subject areas
Adult
Antibodies, Viral
Asymptomatic Infections
Female
Fingolimod Hydrochloride
Humans
Male
Middle Aged
Multiple Sclerosis
Natalizumab
RNA, Viral
Seroepidemiologic Studies
authors with profiles
Fausto Baldanti
Giulia Mallucci
Roberto Bergamaschi
Matteo Gastaldi
Diego Franciotta
Beatrice Dal Fabbro
Antonio Zito